These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

941 related items for PubMed ID: 27550399

  • 1. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D, Pomero F, Benedetti R, Fenoglio L.
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM, Silva MA, Donovan JL, Kanaan AO.
    Clin Ther; 2014 Oct 01; 36(10):1454-64.e3. PubMed ID: 25092394
    [Abstract] [Full Text] [Related]

  • 3. Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.
    Imberti D, Mastroiacovo D.
    Intern Emerg Med; 2017 Aug 01; 12(5):561-563. PubMed ID: 28647891
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S.
    PLoS One; 2016 Aug 01; 11(8):e0160064. PubMed ID: 27487187
    [Abstract] [Full Text] [Related]

  • 5. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C, Alotaibi GS, Alsaleh K, Linkins LA, McMurtry MS.
    Thromb Res; 2015 Feb 01; 135(2):243-8. PubMed ID: 25488466
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S.
    PLoS One; 2015 Feb 01; 10(12):e0144856. PubMed ID: 26716830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
    Sindet-Pedersen C, Pallisgaard JL, Olesen JB, Gislason GH, Arevalo LC.
    Thromb Res; 2015 Oct 01; 136(4):732-8. PubMed ID: 26277682
    [Abstract] [Full Text] [Related]

  • 9. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
    Roetker NS, Lutsey PL, Zakai NA, Alonso A, Adam TJ, MacLehose RF.
    Thromb Haemost; 2018 Sep 01; 118(9):1637-1645. PubMed ID: 30103250
    [Abstract] [Full Text] [Related]

  • 10. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L, Yeoh SE, Ramli A.
    Cochrane Database Syst Rev; 2017 Dec 15; 12(12):CD011088. PubMed ID: 29244199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
    Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, Alonso A.
    Blood Adv; 2018 Feb 13; 2(3):200-209. PubMed ID: 29378726
    [Abstract] [Full Text] [Related]

  • 13. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M.
    J Med Econ; 2015 Jun 13; 18(6):399-409. PubMed ID: 25586203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of direct oral anticoagulants for the treatment of venous thromboembolism in the oncology population.
    Hedvat J, Howlett C, McCloskey J, Patel R.
    J Thromb Thrombolysis; 2018 Nov 13; 46(4):483-487. PubMed ID: 30191357
    [Abstract] [Full Text] [Related]

  • 16. Drug Treatment of Venous Thromboembolism in the Elderly.
    Boey JP, Gallus A.
    Drugs Aging; 2016 Jul 13; 33(7):475-90. PubMed ID: 27255713
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
    Oertel LB, Fogerty AE.
    J Am Assoc Nurse Pract; 2017 Sep 13; 29(9):551-561. PubMed ID: 28805310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.